Smith Stan's Form 4 filing
MAIA Biotechnology, Inc. (MAIA) · filed Mar 1, 2023
- Accession no.
- 0001127602-23-007701
- Filed
- Mar 1, 2023
- Trade date
- Feb 27-28, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $8.23K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith StanCIK 0001913199 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2023 | Common Stock | PPurchaseAcquired | +219 | $4.47 | +$978.93 | 515,766 | Indirect | |
| Feb 28, 2023 | Common Stock | PPurchaseAcquired | +1,619 | $4.48 | +$7,253.12 | 517,385 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.